Vas Narasimhan earned a big pay hike when he moved to the CEO's suite at Novartis
It’s unlikely Vas Narasimhan will rank at the top of any 2018 compensation lists for Big Pharma CEOs. But the Novartis helmsman is definitely on a whole new pay scale compared to what he earned as a drug development chief.
Basic subscription required
Unlock this story instantly and join 58,000+ biopharma pros reading Endpoints daily — and it's free.